Turn Therapeutics【TTRX】銘柄情報

Turn Therapeutics Inc (TTRX) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

7.12

( 3.94% )

買値

6.82

売値

7.90

出来高

20,599

6.83 日の範囲 7.32

2.5701 52 週間の範囲 26.35

時価総額

212.091M

前日終値

6.85

始値

6.94

時刻

6.98

最終取引時間

05:30:43

財務取引量

US$ 145,803

VWAP

7.0782

平均取引量 (3 か月)

US$ 43,309

発行済株式数

29,788,040

配当利回り

PER

-53.94

1 株当たり利益 (EPS)

-0.14

歳入

純利益

-3.84M

Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic through acute and chronic wound care products, enabling healthcare institutions to c... Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. The company was formerly known as Global Health Solutions, Inc and change its name to Turn Therapeutics Inc. in September 2025. Turn Therapeutics Inc. was incorporated in 2015 and is based in Westlake Village, California. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

turntherapeutics.com

本社

Westlake Village, United States

設立

2026

Turn Therapeutics Inc is listed in the Healthcare sector of the ナスダック市場 with ticker TTRX. The last closing price for Turn Therapeutics was US$6.85. Over the last year, Turn Therapeutics shares have traded in a share price range of US$ 2.5701 to US$ 26.35.

Turn Therapeutics currently has 29,788,040 shares in issue. The market capitalisation of Turn Therapeutics is US$212.09 million. Turn Therapeutics has a price to earnings ratio (PE ratio) of -53.94.

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Turn Therapeutics Reports Interim Analysis Findings and Adaptive Optimization Strategy from Phase 2 GX-03 Trial in Moderate-to-Severe Atopic Dermatitis

92.6% of GX-03-treated subjects achieved a 50% reduction in eczema severity in 4 weeks (EASI-50); 70.4% achieved a 75% reduction in 4 weeks...

Form 8-K - Current report

Turn Therapeutics Announces Peer-Reviewed Publication in Journal of Dermatological Treatment Highlighting GX-03 Activity in IL-36 Associated Inflammatory Model

Study demonstrates statistically significant reduction in disease severity in a murine dermatitis model characterized by IL-36 expression First...

Form 8-K - Current report

Turn Therapeutics to Present at Jefferies Global Healthcare Conference 2026

Turn Therapeutics Inc. (Nasdaq: TTRX), a clinical-stage biotechnology company developing targeted, localized therapies for inflammatory skin...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	1.03	16.9129720854	6.09	7.39	5.8403	60041	6.96963602	CS
4	1.14	19.0635451505	5.98	7.39	4.8273	44851	6.21757702	CS
12	3.62	103.428571429	3.5	7.39	3.09	43620	5.27756584	CS
26	2.93	69.9284009547	4.19	7.39	3.01	36563	4.7605079	CS
52	-17.435	-71.0038688658	24.555	26.35	2.5701	123125	6.75186807	CS
156	-17.435	-71.0038688658	24.555	26.35	2.5701	123125	6.75186807	CS
260	-17.435	-71.0038688658	24.555	26.35	2.5701	123125	6.75186807	CS